Inventors of diagnostic signatures

As an innovative company, Skyline is actively seeking academic and industrial partners for development of novel diagnostic products. If you have developed a diagnostic signature, published or unpublished, we will screen it in one month against a comprehensive set of criteria. The result of this process is a transparent scorecard, incorporating scientific value, medical benefits, as well as market considerations. If we both agree on the value of your signature, collaborative development of a novel diagnostic test is possible. We strive to reach a joint conclusion within 2 months and complete the process with a licensing agreement.

Our core competencies are:

• Proven diagnostics track record – Track record in translational development of diagnostics.
• Biomedical science expertise – Team of scientists with biological, medical and diagnostic expertise. Specific knowledge of hematological and oncological indications.
• In-house bioinformatics and biostatistics capabilities
• Regulatory experience – Experience with regulatory processes in Europe (IVD CE-marking) and USA (FDA).
• Clinical trials – Track record in clinical trial organization and management.
• Direct communication – Agile and knowledgeable team with short communication lines.